Thursday, February 2, 2023
Home COVID-19 Coronavirus (COVID-19) Update: June 4, 2021

Coronavirus (COVID-19) Update: June 4, 2021

0
256
For Rapid Launch:

The U.S. Meals and Drug Administration at this time introduced the next actions taken in its ongoing response effort to the COVID-19 pandemic:

  • On June 1, the FDA accepted an abbreviated new drug software for albuterol sulfate inhalation aerosol 90 mcg (base)/actuation. Albuterol sulfate inhalation aerosol is used for the remedy or prevention of bronchospasm (narrowing of the airways) in sufferers 4 years of age and older with reversible obstructive airway illness (comparable to bronchial asthma) and for the prevention of exercise-induced bronchospasm in sufferers 4 years of age and older. The most typical negative effects related to albuterol sulfate inhalation aerosol are headache, dizziness, tachycardia (fast coronary heart charge), chest ache, pharyngitis (sore throat), and rhinitis (runny nostril).
    The FDA acknowledges the elevated demand for sure merchandise throughout the COVID-19 public well being emergency and has prioritized the evaluate of generic drug purposes for potential remedies and supportive therapies for sufferers with COVID-19. We stay deeply dedicated to facilitating entry to secure and efficient medical merchandise to assist deal with vital wants of the American public.
  • On June 3, the FDA posted an replace to the SARS-CoV-2 Viral Mutations: Affect on COVID-19 Assessments internet web page to share the most recent info. The replace added new details about a possible influence on the efficiency of the Mesa Biotech Inc. Accula SARS-CoV-2 Take a look at attributable to a genetic mutation at positions 28877-28878 (AG to TC) in affected person samples.
  • The FDA reissued the Letter of Authorization for REGEN-COV (Casirivimab and Imdevimab) remedy for COVID-19 to authorize:
  • Testing updates:
    • As of at this time, 380 assessments and pattern assortment units are approved by the FDA underneath emergency use authorizations (EUAs). These embrace 275 molecular assessments and pattern assortment units, 80 antibody and different immune response assessments and 25 antigen assessments. There are 52 molecular authorizations and one antibody authorization that can be utilized with home-collected samples. There’s one molecular prescription at-home check, two antigen prescription at-home assessments, 4 antigen over-the-counter (OTC) at-home assessments and two molecular OTC at-home assessments.
    • The FDA has approved 9 antigen assessments and three molecular assessments for serial screening packages. The FDA has additionally approved 525 revisions to EUA authorizations.

Associated Data

###

Boilerplate

The FDA, an company throughout the U.S. Division of Well being and Human Providers, protects the general public well being by assuring the security, effectiveness, and safety of human and veterinary medicine, vaccines and different organic merchandise for human use, and medical units. The company is also answerable for the security and safety of our nation’s meals provide, cosmetics, dietary dietary supplements, merchandise that give off digital radiation, and for regulating tobacco merchandise.


LEAVE A REPLY

Please enter your comment!
Please enter your name here